NASHUA, N.H., Dec. 06, 2021 (GLOBE NEWSWIRE) —
iCAD, Inc.
(NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that Stacey Stevens, President and incoming Chief Executive Officer, will present a corporate overview at Oppenheimer’s Imagine AI + Healthcare Investor Summit being hosted by Oppenheimer in partnership with the Alliance for AI in Healthcare (AAIH).
Oppenheimer’s Imagine AI + Healthcare Investor Summit
Date: Tuesday, December 7
th
Time: 11:00 a.m. to 11:20 a.m. ET
Registration Link
About iCAD, Inc.
Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit
www.icadmed.com
.
Contact:
Media Inquiries:
Jessica Burns, iCAD
+1-201-423-4492
[email protected]
Investor Relations:
Brian Ritchie, LifeSci Advisors
+ 1-212-915-2578
[email protected]
